H-3 SCH-23390 BINDING-SITES IN THE RAT SUBSTANTIA-NIGRA - EVIDENCE FOR A PRESYNAPTIC LOCALIZATION AND INNERVATION BY DOPAMINE

被引:91
作者
PORCEDDU, ML [1 ]
GIORGI, O [1 ]
ONGINI, E [1 ]
MELE, S [1 ]
BIGGIO, G [1 ]
机构
[1] ESSEX ITALIA SPA, RES LABS, MILAN, ITALY
关键词
D O I
10.1016/0024-3205(86)90650-8
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:321 / 328
页数:8
相关论文
共 20 条
[1]   INHIBITION BY APOMORPHINE OF THE POTASSIUM-EVOKED RELEASE OF (H-3)-GAMMA-AMINOBUTYRIC ACID FROM THE RAT SUBSTANTIA NIGRA INVITRO [J].
ARBILLA, S ;
KAMAL, LA ;
LANGER, SZ .
BRITISH JOURNAL OF PHARMACOLOGY, 1981, 74 (02) :389-397
[2]   DENERVATION SUPER-SENSITIVITY FOR BENZODIAZEPINE RECEPTORS IN THE RAT SUBSTANTIA NIGRA [J].
BIGGIO, G ;
CORDA, MG ;
CONCAS, A ;
GESSA, GL .
BRAIN RESEARCH, 1981, 220 (02) :344-349
[3]   CHARACTERIZATION OF THE BINDING OF H-3-SCH 23390, A SELECTIVE D-1 RECEPTOR ANTAGONIST LIGAND, IN RAT STRIATUM [J].
BILLARD, W ;
RUPERTO, V ;
CROSBY, G ;
IORIO, LC ;
BARNETT, A .
LIFE SCIENCES, 1984, 35 (18) :1885-1893
[4]   ANTI-SCHIZOPHRENIC DRUGS - CHRONIC TREATMENT ELEVATES DOPAMINE RECEPTOR-BINDING IN BRAIN [J].
BURT, DR ;
CREESE, I ;
SNYDER, SH .
SCIENCE, 1977, 196 (4287) :327-328
[5]   INSITU INJECTION OF KAINIC ACID - NEW METHOD FOR SELECTIVELY LESIONING NEURONAL CELL BODIES WHILE SPARING AXONS OF PASSAGE [J].
COYLE, JT ;
MOLLIVER, ME ;
KUHAR, MJ .
JOURNAL OF COMPARATIVE NEUROLOGY, 1978, 180 (02) :301-323
[6]  
CREESE I, 1983, RECEPTORS SUPRAMOLEC, P1
[7]   EFFECT OF DISCRETE KAINIC ACID-INDUCED LESIONS OF CORPUS CAUDATUS AND GLOBUS PALLIDUS ON GLUTAMIC-ACID DECARBOXYLASE OF RAT SUBSTANTIA NIGRA [J].
DICHIARA, G ;
MORELLI, M ;
PORCEDDU, ML ;
MULAS, M ;
DELFIACCO, M .
BRAIN RESEARCH, 1980, 189 (01) :193-208
[8]   DOPAMINE-SENSITIVE ADENYLATE-CYCLASE - LOCATION IN SUBSTANTIA NIGRA [J].
GALE, K ;
GUIDOTTI, A ;
COSTA, E .
SCIENCE, 1977, 195 (4277) :503-505
[9]   SCH-23390 - THE 1ST SELECTIVE DOPAMINE D-1 ANTAGONIST [J].
HYTTEL, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1983, 91 (01) :153-154
[10]  
IORIO LC, 1983, J PHARMACOL EXP THER, V226, P462